Postoperative decrease in plasma acyl ghrelin levels after pediatric living donor liver transplantation in association with hepatic damage due to ischemia and reperfusion injury.
Children
Ghrelin
Liver transplantation
Journal
Pediatric surgery international
ISSN: 1437-9813
Titre abrégé: Pediatr Surg Int
Pays: Germany
ID NLM: 8609169
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
accepted:
11
02
2019
pubmed:
7
3
2019
medline:
1
8
2019
entrez:
7
3
2019
Statut:
ppublish
Résumé
Ghrelin was recently reported to promote recovery from hepatic injury. We hypothesized that it could also be associated with clinical recovery of the transplanted liver from ischemia and reperfusion injury. Our aims were to investigate perioperative ghrelin changes following pediatric living donor liver transplantation (LDLT) and to analyze the association of these changes with postoperative hepatic function. We measured plasma acyl ghrelin (AG) concentrations before surgery, at the end of surgery and on postoperative days (PODs) 1, 3 and 7 in 12 children who underwent LDLTs, and, as controls, pre- and post-operatively and on POD1 in 7 children who underwent benign abdominal mass resection. The correlations between the participants' ghrelin profiles and hepatic function-related data were evaluated. AG levels significantly declined to 15.6% of preoperative levels after LDLT and almost returned to baseline on POD3. Post-operative AG levels were significantly reduced to a greater extent following LDLT than benign abdominal mass resection. AG levels on POD1 inversely correlated with aspartate aminotransferase levels and cold/total ischemia time (P < 0.05). These results suggest that reduced AG levels on POD1 may reflect the degree of damage to the transplanted liver due to ischemia and reperfusion injury.
Identifiants
pubmed: 30838440
doi: 10.1007/s00383-019-04463-8
pii: 10.1007/s00383-019-04463-8
doi:
Substances chimiques
Ghrelin
0
Aspartate Aminotransferases
EC 2.6.1.1
Types de publication
Journal Article
Langues
eng
Pagination
709-714Subventions
Organisme : KAKENHI
ID : 16K09966
Références
Nature. 1999 Dec 9;402(6762):656-60
pubmed: 10604470
Biochem Biophys Res Commun. 2000 Oct 5;276(3):905-8
pubmed: 11027567
Endocrinology. 2000 Nov;141(11):4255-61
pubmed: 11089560
Biochem Biophys Res Commun. 2000 Dec 29;279(3):909-13
pubmed: 11162448
Nature. 2001 Jan 11;409(6817):194-8
pubmed: 11196643
Circulation. 2001 Sep 18;104(12):1430-5
pubmed: 11560861
Liver Transpl. 2003 Jul;9(7):651-63
pubmed: 12827549
Eur J Endocrinol. 2004 Apr;150(4):447-55
pubmed: 15080773
Circulation. 2004 May 11;109(18):2221-6
pubmed: 15117840
J Clin Endocrinol Metab. 2005 Apr;90(4):2205-11
pubmed: 15657369
J Surg Res. 2006 Jan;130(1):1-7
pubmed: 16182310
Surgery. 2006 Jun;139(6):797-805
pubmed: 16782437
Regul Pept. 2008 Feb 7;146(1-3):73-9
pubmed: 17884193
Peptides. 2010 Nov;31(11):2114-7
pubmed: 20727930
Eur J Endocrinol. 2012 Feb;166(2):235-40
pubmed: 22048973
J Biomed Biotechnol. 2012;2012:298657
pubmed: 22649277
Liver Int. 2014 Apr;34(4):567-75
pubmed: 23998356
Arch Trauma Res. 2013 Aug;2(2):63-70
pubmed: 24396796
J Surg Res. 2015 Dec;199(2):450-7
pubmed: 26205310
Biomed Pharmacother. 2016 Dec;84:305-313
pubmed: 27665476
Endocr Connect. 2017 Nov;6(8):847-855
pubmed: 29038331